{"id":217638,"date":"2023-03-16T06:24:00","date_gmt":"2023-03-16T12:24:00","guid":{"rendered":"http:\/\/vertienteglobal.com\/?p=217638"},"modified":"2023-03-16T06:36:15","modified_gmt":"2023-03-16T12:36:15","slug":"moderna-y-merck-desarrollan-vacuna-contra-el-cancer","status":"publish","type":"post","link":"http:\/\/vertienteglobal.com\/?p=217638","title":{"rendered":"Moderna y Merck desarrollan vacuna contra el c\u00e1ncer"},"content":{"rendered":"\n<div class=\"twitterbutton\" style=\"float: right; padding-left: 5px;\"><a href=\"http:\/\/twitter.com\/share\" class=\"twitter-share-button\" data-count=\"horizontal\" data-text=\"Moderna y Merck desarrollan vacuna contra el c\u00e1ncer\" data-via=\"https:\/\/twitter.com\/VertienteGloba1\" data-url=\"http:\/\/vertienteglobal.com\/?p=217638\" data-lang=\"es\" data-related=\"Informaci\u00f3n general:S\u00edguenos para que est\u00e9ss informado\"><\/a><\/div>\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"http:\/\/vertienteglobal.com\/wp-content\/uploads\/2023\/03\/201291.jpg\" alt=\"\" class=\"wp-image-217639\" srcset=\"http:\/\/vertienteglobal.com\/wp-content\/uploads\/2023\/03\/201291.jpg 1024w, http:\/\/vertienteglobal.com\/wp-content\/uploads\/2023\/03\/201291-300x200.jpg 300w, http:\/\/vertienteglobal.com\/wp-content\/uploads\/2023\/03\/201291-150x100.jpg 150w, http:\/\/vertienteglobal.com\/wp-content\/uploads\/2023\/03\/201291-768x512.jpg 768w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>(Redacci\u00f3n\/Agencias)<\/p>\n\n\n\n<p>La vacuna ser\u00e1 presentada en el American Association of Cancer Research Meeting 2O23 en Orlando, Florida del 14 al 19 de abril pr\u00f3ximo<\/p>\n\n\n\n<p>Ciudad de M\u00e9xico 16 de marzo 2023.-La farmac\u00e9utica Moderna anunci\u00f3 que trabaja en la fase dos de su vacuna contra el c\u00e1ncer de piel (mRNA-4156\/v940), desarrollada junto a Merck.<\/p>\n\n\n\n<p>De acuerdo con la farmac\u00e9utica, la vacuna ser\u00e1 presentada en el American Association of Cancer Research Meeting 2O23 en Orlando, Florida del 14 al 19 de abril pr\u00f3ximo.<\/p>\n\n\n\n<p>Esta vacuna desarrollada entre ambas farmac\u00e9uticas se trata de una vacuna personalizada contra el c\u00e1ncer que est\u00e1n dise\u00f1adas para preparar el sistema inmunitario de modo que un paciente pueda generar una respuesta antitumoral personalizada espec\u00edfica para su firma de mutaci\u00f3n tumoral.<\/p>\n\n\n\n<p>mRNA-4157\/V940 es una nueva vacuna personalizada contra el c\u00e1ncer basada en \u00e1cido ribonucleico mensajero (ARNm) en investigaci\u00f3n que consiste en un solo ARNm sint\u00e9tico que codifica hasta 34 neoant\u00edgenos que se dise\u00f1a y produce en funci\u00f3n de la firma mutacional \u00fanica del tumor del paciente.(Fuente:Infobae)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(Redacci\u00f3n\/Agencias) La vacuna ser\u00e1 presentada en el American Association of Cancer Research Meeting 2O23 en Orlando, Florida del 14 al 19 de abril pr\u00f3ximo Ciudad de M\u00e9xico 16 de marzo 2023.-La farmac\u00e9utica Moderna anunci\u00f3 que trabaja en la fase dos de su vacuna contra el c\u00e1ncer de piel (mRNA-4156\/v940), desarrollada junto a Merck. De acuerdo [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":217639,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[],"class_list":["post-217638","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pais","entry","has-media"],"jetpack_featured_media_url":"http:\/\/vertienteglobal.com\/wp-content\/uploads\/2023\/03\/201291.jpg","_links":{"self":[{"href":"http:\/\/vertienteglobal.com\/index.php?rest_route=\/wp\/v2\/posts\/217638","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/vertienteglobal.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/vertienteglobal.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/vertienteglobal.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/vertienteglobal.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=217638"}],"version-history":[{"count":0,"href":"http:\/\/vertienteglobal.com\/index.php?rest_route=\/wp\/v2\/posts\/217638\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/vertienteglobal.com\/index.php?rest_route=\/wp\/v2\/media\/217639"}],"wp:attachment":[{"href":"http:\/\/vertienteglobal.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=217638"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/vertienteglobal.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=217638"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/vertienteglobal.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=217638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}